98 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Monthly information regarding the total number of voting rights ans shares making of the share capital - november As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
08/12/2022 | Voting rights | |
Buyback programs - november 2022 Monthly communication regarding buyback programs |
08/12/2022 | Description of buyback programs | |
Monthly communication regarding buyback programs - october 2022 |
10/11/2022 | Voting rights | |
Buyback programs - october 2022 Monthly communication regarding buyback programs |
10/11/2022 | Description of buyback programs | |
First nine months 2022 sales: €405M In line with year-end outlook |
12/10/2022 | Public releases | |
Monthly communication regarding buyback programs - September 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
05/10/2022 | Voting rights | |
Buyback programs - september 2022 Monthly communication regarding buyback programs |
05/10/2022 | Description of buyback programs | |
2022 HALF YEAR RESULTS Additional information on the Group’s strategy Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol would like to provide some additional information on the strategy implemented and its outlook. |
23/09/2022 | Public releases , Half Year Report | |
2022 half-year results This document has been prepared by Vetoquinol for the sole purpose of presenting the half-year results for the fiscal year 2022, on September 15, 2022. |
15/09/2022 | Half Year Report | |
2022 HALF YEAR RESULTS Sales: €271m (up 6.0% as reported) |
15/09/2022 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2022 As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
06/09/2022 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - July 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
22/08/2022 | Voting rights | |
H1 2022 Sales H1 2022 Sales: €271m, up 6.1% |
20/07/2022 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - june 2022 as per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
05/07/2022 | Voting rights | |
Buyback programs - may 2022 Monthly communication regarding buyback programs |
03/06/2022 | Monthly communication regarding buyback programs | |
Monthly information regarding the total number of voting rights and shares making of the share capital - may 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
03/06/2022 | Voting rights | |
Remuneration vote results - AG may 2022 |
20/05/2022 | Shareholders´s Meeting | |
Vote results - AG may 19, 2022 |
20/05/2022 | Shareholders´s Meeting | |
Information regarding the total number of voting rights and shares making of the share capital - 12 may 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
13/05/2022 | Shareholders´s Meeting | |
Monthly information regarding the total number of voting rights and shares making of the share capital - april 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
05/05/2022 | Voting rights | |
Buyback programs - april 2022 Monthly communication regarding buyback programs |
05/05/2022 | Monthly communication regarding buyback programs | |
Universal registration document 2021 Universal Registration Document including the Annual Financial Report |
05/05/2022 | Reference document | |
Balo new information Balo new information |
05/05/2022 | Shareholders´s Meeting | |
Number of voting rights and shares making of the share capital Information regarding the total number of voting rights and shares making of the share capital - J-21 before AGM as per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
03/05/2022 | Shareholders´s Meeting | |
Annual general meeting 2022 - brochure |
28/04/2022 | Shareholders´s Meeting | |
Availability of the 2021 universal registration document Vetoquinol informs that it has filed its 2021 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 22th, 2022. |
22/04/2022 | Public releases | |
Vote by post / proxy form Vote by post of proxy form for annual general meeting on May 19, 2022 |
19/04/2022 | Shareholders´s Meeting | |
General annual meeting - may 19 2022 Annual General Meeting on May 19, 2022 - convocation |
19/04/2022 | Shareholders´s Meeting | |
Q1 2022 SALES: €135M Q1 2022 SALES: €135M |
13/04/2022 | Public releases | |
Buyback programs - march 2022 Monthly communication regarding buyback programs |
06/04/2022 | Monthly communication regarding buyback programs | |
Monthly information regarding the total number of voting rights and shares - march 2022 Monthly information regarding the total number of voting rights and shares making of the share capital as per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
06/04/2022 | Voting rights | |
2021 Annual results ALL FINANCIAL INDICATORS UP. |
24/03/2022 | Public releases | |
Annual results 2021 (slideshow) This document was prepared by Vetoquinol for the sole purpose of presenting the annual results for the year 2021 on March 24, 2022. |
24/03/2022 | Annual Report | |
[AUDIO] Présentation des résultats 2021 Présentation analystes & investisseurs - 24 mars 2022 |
24/03/2022 | Annual Report | |
Monthly information regarding the total number of voting rights and shares making of the share capital- february 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
04/03/2022 | Voting rights | |
Buyback programs - february 2022 Buyback programs - February 2022 |
04/03/2022 | Monthly communication regarding buyback programs | |
Buyback programs - January 2022 |
07/02/2022 | Monthly communication regarding buyback programs | |
Double-digit growth in 2021 Total Group Sales: €521 million (up 21.9% as reported) |
20/01/2022 | Public releases | |
Clone of Monthly information regarding the total number of voting rights and shares making of the share capital As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
06/01/2022 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
06/01/2022 | Voting rights | |
Programme de rachat - Décembre 2021 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres. |
04/01/2022 | Monthly communication regarding buyback programs | |
Bilan annuel des moyens alloués au contrat de liquidité (décembre 2021) Au titre du contrat de liquidité confié par la Société VETOQUINOL à la Société ODDO CORPORATE FINANCE, les moyens suivants figuraient au compte de liquidité au 31 décembre 2021 |
04/01/2022 | Liquidity contract | |
2021 calendar of financial communication December 15, 2020 (Lure, France) - Vetoquinol published its calendar of financial communication for 2021. |
15/12/2020 | Agenda | |
Programme de rachat - November 2020 |
03/12/2020 | Monthly communication regarding buyback programs | |
Monthly information regarding the total number of voting rights and shares making of the share capital - November 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
03/12/2020 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - October2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
04/11/2020 | Voting rights | |
Programme de rachat - October 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
04/11/2020 | Monthly communication regarding buyback programs | |
Q3 2020 sales: €114.5 million* (Up 14.3%) Vetoquinol posted sales of €114.5 million for the third quarter of 2020, up 14.3% as reported compared to the same period last year. |
15/10/2020 | Public releases | |
Programme de rachat - September 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
05/10/2020 | Monthly communication regarding buyback programs | |
Monthly information regarding the total number of voting rights and shares making of the share capital -September 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers »
|
05/10/2020 | Voting rights | |
VETOQUINOL, SNGTV and FARMVETSYSTEMS sign a partnership agreement to offer a common, innovative digital solution to the veterinary healthcare market. September 28th, 2020 (Paris, France) VETOQUINOL, FARMVET SYSTEMS and SNGTV have signed a partnership agreement aimed at offering a common solution highlighting the complementarity of their two software, VetIMPRESS and Vetélevage to farm vets. Aware of their shared philosophy aimed at optimizing vets actions thanks to new digital technologies, they are pooling these two software programs to strengthen the role of farm vets in animal health and welfare. |
28/09/2020 | Public releases | |
Vetimpress delivering digital solutions to farm vets with a growing network of partnerships September 21st, 2020 (Northern Ireland) – VetIMPRESS the secure data management platform has recently implemented a series of integrations, reinforcing its position as a leading source of information for farm animal vets. The platform has grown its connections to over 100 external sources across 10 countries. The partnerships are set to improve connectivity across the industry, providing a single source of truth to better inform ethical, safe and productive veterinary decisions. |
21/09/2020 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital -Aout 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
03/09/2020 | Voting rights | |
Programme de rachat - August 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
03/09/2020 | Monthly communication regarding buyback programs | |
Vetoquinol finalizes the acquisition of Profender® and Drontal® product families September 1st, 2020 (Lure, France) – Vetoquinol confirms the completion of the acquisition of Profender® and Drontal® product families for the European Economic Area and the UK. This acquisition is effective from August 1st, 2020. |
02/09/2020 | Public releases | |
Programme de rachat - July 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
24/08/2020 | Monthly communication regarding buyback programs | |
Monthly information regarding the total number of voting rights and shares making of the share capital -July 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
24/08/2020 | Voting rights | |
2020 Half year Financial Report (french) Half year Financial Report |
31/07/2020 | Half Year Report | |
[VIDEO] Présentation des résultats semestriels 2020 - french |
31/07/2020 | Half Year Report | |
H1 2020 results H1 2020 Result
|
30/07/2020 | Half Year Report | |
2020 first half results consolidated sales: €196.1m (up 7.5% at constant exchange rates) net income group share: €15.1m (7.7% of sales) At its meeting on July 29, 2020, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the first half 2020 financial statements. The auditors have completed their audit of the financial statements and will shortly issue their report thereon. |
30/07/2020 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital -June 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
06/07/2020 | Voting rights | |
Bilan semestriel des moyens alloués au contrat de liquidité - french Au titre du contrat de liquidité confié par la Société VETOQUINOL à la Société ODDO CORPORATE FINANCE, les moyens suivants figuraient au compte de liquidité au 30 juin 2020 |
02/07/2020 | Liquidity contract | |
Programme de rachat - June 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
02/07/2020 | Monthly communication regarding buyback programs | |
Vetoquinol is moving forward with the acquisition of Profender® and Drontal® and related pipeline assets following communication from the European commission June 9th, 2020 (Lure, France) - The European Commission (EC) has approved, under the EU merger Regulation, the proposed acquisition of Bayer’s Animal Health Division by Elanco Animal Health. |
09/06/2020 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital -May 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
04/06/2020 | Voting rights | |
Programme de rachat - May 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
04/06/2020 | Monthly communication regarding buyback programs | |
Rémunération et politique des dirigeants (french) Résultats des votes de l’Assemblée Générale Mixte du 26 mai 2020 |
29/05/2020 | Shareholders´s Meeting | |
Descriptif du programme de rachat d’actions propres soumis à l’assemblée générale mixte du 26 mai 2020 (french) Établi en application des dispositions des articles 241-1 et suivant du règlement général de l’Autorité des marchés financiers, le présent descriptif de programme de rachat d’actions propres a pour objet de décrire les finalités et les modalités du programme de rachat d’actions autorisé par l’assemblée générale mixte du 26 mai 2020. |
27/05/2020 | Description of buyback programs | |
Combined Ordinary and Extraordinary General Meeting of May 26, 2020 The Combined Ordinary and Extraordinary General Meeting of Vetoquinol shareholders was held on Tuesday May 26, 2020 in Lure, chaired by Etienne Frechin. The shareholders did not physically attend this meeting in view of the restrictions on gatherings due to the health crisis in France. |
27/05/2020 | Shareholders´s Meeting | |
Résultats du scrutin de l'Assemblée Générale mixte du 26 mai 2020 (french) Résultats du scrutin |
27/05/2020 | Shareholders´s Meeting | |
Assemblée Générale Annuelle Mixte (french) 26 mai 2020 |
26/05/2020 | Shareholders´s Meeting | |
Brochure Vetoquinol AGM en huis clos Mesdames et Messieurs les actionnaires,
Le conseil d’administration a décidé de faire usage des dispositions de l’ordonnance n°2020-321 du 25 mars 2020 portant adaptation des règles de réunion et de délibération des assemblées et organes dirigeants des personnes morales et entités dépourvues de personnalité morale de droit privé en raison de la crise sanitaire actuelle et des restrictions de déplacement et réunion qu’elle impose. En conséquence, l’assemblée générale mixte de VETOQUINOL SA se tiendra le mardi 26 mai 2020 à 14h45, au siège social, Magny-Vernois 70 200 LURE, à huis clos, sans que les actionnaires et les autres personnes ayant le droit d’y assister ne soient présents physiquement.
|
07/05/2020 | Shareholders´s Meeting | |
Monthly information regarding the total number of voting rights and shares making of the share capital - April 2020 |
06/05/2020 | Voting rights | |
Programme de rachat - April 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
06/05/2020 | Monthly communication regarding buyback programs | |
Dominique Derveaux appointed Group Chief Operations Officer
Effective April 1, 2020, Vetoquinol’s Board of Directors has appointed Dominique Derveaux Group Chief Operations Officer. In this capacity, he will run the Business, Marketing & Medical, Industrial, and Information Systems departments. He will report to Vetoquinol CEO Matthieu Frechin. |
28/04/2020 | Public releases | |
Availability of the 2019 universal registration document Vetoquinol informs that it has filed its 2019 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 23, 2020. |
23/04/2020 | Public releases | |
2019 Universal registration document Note to recipient of this document: this is the translation of an extract of the Universal Registration Document and Annual Financial Report for the year ended December 31, 2019. The original French document was filed with the AMF (French Financial Markets Authority) on April 23, 2020.
|
23/04/2020 | Reference document | |
Q1 2020 sales €103.4 million (Up 13.7%) Vetoquinol Group sales for Q1 2020 amounted to €103.4 million, up 13.7% as reported and up 13.4% at constant exchange rates. |
16/04/2020 | Public releases | |
Formulaire de vote Formulaire de vote - Assemblée générale mixte - 26 mai 2020 - siège social Magny-Vernois 70200 LURE |
16/04/2020 | Shareholders´s Meeting | |
Avis de réunion valant avis de convocation (french) Mesdames et Messieurs les actionnaires sont convoqués le mardi 26 mai 2020 à 14h45, au siège social, Magny-Vernois 70 200 LURE, en Assemblée générale mixte, à l’effet de délibérer sur l’ordre du jour et les projets de résolutions suivants : |
16/04/2020 | Shareholders´s Meeting | |
Monthly information regarding the total number of voting rights and shares making of the share capital - MArch 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
06/04/2020 | Voting rights | |
Programme de rachat - March 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
06/04/2020 | Monthly communication regarding buyback programs | |
Information hebdomadaire relative aux transactions réalisées sur ses propres titres (30 mars 2020) Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers |
30/03/2020 | Monthly communication regarding buyback programs | |
[AUDIO] Présentation des résultats 2019 Présentation analystes & investisseurs - 26 mars 2020 |
26/03/2020 | Annual Report | |
2019 annual results
|
26/03/2020 | Annual Report | |
2019 annual results: group sales €396.0M, up 6.1% at constant exchange rates. Net income group share: €28.6M (7.2% of sales) At its meeting on March 24, 2020, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the 2019 financial statements. The auditors have completed their audit of the financial statements and will shortly issue their report thereon. |
26/03/2020 | Public releases | |
Information hebdomadaire relative aux transactions réalisées sur ses propres titres (23 mars 2020) Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers |
23/03/2020 | Monthly communication regarding buyback programs | |
Covid-19: Vetoquinol donates masks to neighboring healthcare facilities Vetoquinol S.A, the animal health laboratory based in Lure (70) has decided to donate more than 6000 masks to hospitals and associations in the region. This is a civic action to help, amongst others, hospitals in the Belfort Montbéliard, Vesoul and Saint-Rémy regions. |
20/03/2020 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - February 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
04/03/2020 | Voting rights | |
Programme de rachat - February 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
04/03/2020 | Monthly communication regarding buyback programs | |
Vetoquinol to acquire rights for Profender® and Drontal® from Elanco Animal Health for the European economic area and the UK February 12 th , 2020 (Lure, France) - Vetoquinol has agreed terms to acquire the European Economic area and UK rights to Profender® and Drontal® product families from Elanco Animal Health. |
12/02/2020 | Public releases | |
Programme de rachat - January 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
07/02/2020 | Monthly communication regarding buyback programs | |
Monthly information regarding the total number of voting rights and shares making of the share capital - January 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
07/02/2020 | Voting rights | |
2019 sales: €396.0 million (Up 7.6%) The Vetoquinol Group posted 2019 sales of €396.0 million, up 7.6% as reported and up 6.1% at constant exchange rates. |
23/01/2020 | Public releases | |
Bilan semestriel des moyens alloués au contrat de liquidité - french Au titre du contrat de liquidité confié par la Société VETOQUINOL à la Société ODDO CORPORATE FINANCE, les moyens suivants figuraient au compte de liquidité au 31 décembre 2019 |
06/01/2020 | Liquidity contract | |
Monthly information regarding the total number of voting rights and shares making of the share capital - December 2019 |
06/01/2020 | Voting rights | |
Programme de rachat - December 2019 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
06/01/2020 | Monthly communication regarding buyback programs |